INNOVAQOR INC - INQR STOCK NEWS

InnovaQor, Inc. (OTC: INQR) CEO Darrell Peterson's Year-End Message to Shareholders

InnovaQor, Inc. (OTC: INQR) CEO Darrell Peterson provided an update on the development of Curallo, a next-generation platform for medical professionals, and discussed the contemplated share exchange offer to reduce the number of common shares outstanding. The company also confirmed renewed sales and marketing efforts to add more revenue from existing products.

InnovaQor, Inc. (INQR) authorizes two new series of preferred stock, Series E and Series F, for potential exchange offer to common shareholders. The Series E Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2026, and the Series F Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2027. The stated value of each series of preferred stock initially is $100, increasing by $20 upon each anniversary of issuance. The exchange offer is being considered as an alternative to completing a reverse split of common stock to attract new investors. The terms and timing of the exchange offer are subject to final approval by the Board of Directors and market conditions.

InnovaQor CEO confirms development of new product Curallo, a healthcare communication platform. Company aims for increased revenues from EHR product and IT services. Curallo website launched for user input and updates. Ambition to list on stock exchange.

The subsidiary of InnovaQor, Medical Mime, has launched an automated billing solution designed to enhance the efficiency of Electronic Health Records (EHR) software for behavioral health and substance abuse facilities. This solution aims to simplify claim processing by ensuring that clean claims are submitted, which could potentially lead to fewer claim denials. Compatible with both HCFA 1500 and UB-04 claims, the system is flexible and customizable to meet specific client needs. According to CEO Sharon Hollis, the innovation is expected to streamline billing communication and improve overall billing performance.

InnovaQor, Inc. (OTC: INQR) has partnered with XCPCNL Business Services Corporation to enhance its marketing strategy for healthcare software products. Signed on February 24, the agreement aims to develop a targeted sales approach that utilizes XCPCNL's AI technology to boost sales and market presence.

Sharon Hollis, CEO of InnovaQor, expresses optimism about the collaboration, anticipating increased market opportunities. The agreement includes a 90-day termination clause and presents potential for joint ventures. The partnership aims to expedite the introduction of InnovaQor's brand across various channels.